TY - JOUR
T1 - Fruits, vegetables, and micronutrient intake in relation to breast cancer survival
AU - Fink, Brian N.
AU - Gaudet, Mia M.
AU - Britton, Julie A.
AU - Abrahamson, Page E.
AU - Teitelbaum, Susan L.
AU - Jacobson, Judith
AU - Bell, Paula
AU - Thomas, Joyce A.
AU - Kabat, Geoffrey C.
AU - Neugut, Alfred I.
AU - Gammon, Marilie D.
N1 - Funding Information:
David Camann, BS; Martin Trent, BS; Ruby Senie, PhD; Carla Maffeo, PhD; Pat Montalvan; Gertrud Berkowitz, PhD; Margaret Kemeny, MD; Mark Citron, MD; Freya Schnabel, MD; Allen Schuss, MD; Steven Hajdu, MD; and Vincent Vinceguerra, MD. This work was supported in part by grants from the National Cancer Institute and the National Institutes of Environmental Health and Sciences (Grant nos. UO1CA/ ES66572, UO1CA66572, CA52283, and P30ES10126), the National Institutes of Health (Grant no. 5T32CA009330-25), and from the Lance Armstrong Foundation.
PY - 2006/7
Y1 - 2006/7
N2 - Objective. To determine whether fruit, vegetable, and micronutrient intake 1 year prior to breast cancer diagnosis is associated with a reduction in the subsequent risk of all-cause or breast cancer-specific mortality. Methods. Follow-up data from 1,235 invasive breast cancer cases age 25-98 years from the Long Island Breast Cancer Study Project were analyzed. At the 1996-1997 case-control interview, respondents completed a food frequency questionnaire, which assessed dietary intake of fruits, vegetables, and vitamin supplement use in the previous 12 months. All-cause mortality (n=186 deaths) and breast cancer-specific mortality status (n=125 deaths, 67.2%) were determined through December 31, 2002. Results. Hazard ratios (HRs) for all-cause mortality were insignificantly reduced for intake of any fruits, fruit juices, and vegetables (HR=0.68, 95% CI: 0.42-1.09) and leafy vegetables (HR=0.72, 95% CI: 0.41-1.24) among post-menopausal women only. Both of these associations were more pronounced among those with ER+PR+ tumors (HR=0.54, 95% CI: 0.27-1.10, and HR=0.66, 95% CI: 0.33-1.31, respectively). Similar associations were observed for breast cancer-specific mortality. Conclusions. In a cohort of women diagnosed with breast cancer, higher intake of fruits, vegetables, and micronutrients was associated with a non-significant survival advantage in post-menopausal women only.
AB - Objective. To determine whether fruit, vegetable, and micronutrient intake 1 year prior to breast cancer diagnosis is associated with a reduction in the subsequent risk of all-cause or breast cancer-specific mortality. Methods. Follow-up data from 1,235 invasive breast cancer cases age 25-98 years from the Long Island Breast Cancer Study Project were analyzed. At the 1996-1997 case-control interview, respondents completed a food frequency questionnaire, which assessed dietary intake of fruits, vegetables, and vitamin supplement use in the previous 12 months. All-cause mortality (n=186 deaths) and breast cancer-specific mortality status (n=125 deaths, 67.2%) were determined through December 31, 2002. Results. Hazard ratios (HRs) for all-cause mortality were insignificantly reduced for intake of any fruits, fruit juices, and vegetables (HR=0.68, 95% CI: 0.42-1.09) and leafy vegetables (HR=0.72, 95% CI: 0.41-1.24) among post-menopausal women only. Both of these associations were more pronounced among those with ER+PR+ tumors (HR=0.54, 95% CI: 0.27-1.10, and HR=0.66, 95% CI: 0.33-1.31, respectively). Similar associations were observed for breast cancer-specific mortality. Conclusions. In a cohort of women diagnosed with breast cancer, higher intake of fruits, vegetables, and micronutrients was associated with a non-significant survival advantage in post-menopausal women only.
KW - Antioxidants
KW - Breast cancer mortality
KW - Follow-up study
KW - Fruits
KW - Long Island
KW - Survival
KW - Vegetables
UR - https://www.scopus.com/pages/publications/33745907303
U2 - 10.1007/s10549-005-9150-3
DO - 10.1007/s10549-005-9150-3
M3 - Article
C2 - 16538530
AN - SCOPUS:33745907303
SN - 0167-6806
VL - 98
SP - 199
EP - 208
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -